Suppr超能文献

中年和老年非酒精性脂肪性肝病患者的长期生活方式干预:一项随机对照试验。

Long-term lifestyle interventions in middle-aged and elderly men with nonalcoholic fatty liver disease: a randomized controlled trial.

机构信息

Department of Gastroenterology, Huadong Hospital, Shanghai Medical College, Fudan University, No. 221 Yan'an West Road, Shanghai 200040, P.R. China.

Shanghai Key Laboratory of Clinical Geriatric Medicine, No. 221 Yan'an West Road, Shanghai 200040, P.R. China.

出版信息

Sci Rep. 2016 Nov 10;6:36783. doi: 10.1038/srep36783.

Abstract

Nonalcoholic fatty liver disease (NAFLD), a metabolic disorder related to insulin resistance and metabolic syndrome, has become a public health concern. Currently, the principal therapeutic modalities targeting NAFLD are lifestyle interventions. However, the efficacy of long-term lifestyle interventions in managing NAFLD remains largely unexplored. This study aimed to evaluate the efficacy of long-term lifestyle interventions in middle-aged and elderly men with NAFLD. All 280 eligible patients were randomized to the control or test group. Patients in the test group received counseling on diet and exercise from 2 physicians every 3 months via a phone call. Patients in the control group received only counseling in annual checkups without regular intervention. After the 2-year periodic intervention, body weight, abdominal circumference, ALT, TCH, LDL-C and HDL-C decreased in the test group. Specifically, the fatty liver index (FLI) and NAFLD-fibrosis score (NAFLD-FS) reduced markedly in the test group. However, in the control group, there was only a significant decrease in LDL-C, HDL-C and NAFLD-FS (P < 0.001). The liver steatosis grade of the test group decreased significantly, while it increased in the control group. In NAFLD, long-term lifestyle interventions exert an anti-obesity effect and attenuate liver dysfunction and steatosis.

摘要

非酒精性脂肪性肝病(NAFLD)是一种与胰岛素抵抗和代谢综合征相关的代谢紊乱疾病,已成为公共卫生关注的焦点。目前,针对 NAFLD 的主要治疗方法是生活方式干预。然而,长期生活方式干预治疗 NAFLD 的疗效在很大程度上仍未得到探索。本研究旨在评估长期生活方式干预对中年和老年男性 NAFLD 的疗效。所有 280 名符合条件的患者被随机分为对照组和试验组。试验组的患者每 3 个月由 2 名医生通过电话接受饮食和运动方面的咨询。对照组的患者仅在年度体检时接受咨询,没有定期干预。经过 2 年的定期干预,试验组的体重、腰围、ALT、TCH、LDL-C 和 HDL-C 均有所下降。具体来说,试验组的脂肪肝指数(FLI)和非酒精性脂肪性肝病纤维化评分(NAFLD-FS)显著降低。然而,在对照组中,只有 LDL-C、HDL-C 和 NAFLD-FS 显著降低(P<0.001)。试验组的肝脂肪变性程度显著下降,而对照组则增加。在非酒精性脂肪性肝病中,长期生活方式干预具有抗肥胖作用,并能减轻肝功能障碍和脂肪变性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f7f3/5103187/714d2ea6af07/srep36783-f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验